Scientists demonstrated that melatonin had several significant effects by reducing CD11b and TLR4 expression, attenuating TLR signaling, genes involved in the inflammasome and had the potential to reduce LPS-induced inflammatory responses.
[Pediatric Research]
6445218 {6445218:TZQ3WXU5} 1 apa 50 default 1 165742 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22TZQ3WXU5%22%2C%22library%22%3A%7B%22id%22%3A6445218%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Huggard%20et%20al.%22%2C%22parsedDate%22%3A%222021-08-16%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EHuggard%2C%20D.%2C%20Kelly%2C%20L.%2C%20Worrall%2C%20A.%2C%20Gallagher%2C%20E.%2C%20Fallah%2C%20L.%2C%20Yoo%2C%20L.%20L.%2C%20McGrane%2C%20F.%2C%20Lagan%2C%20N.%2C%20Roche%2C%20E.%2C%20Balfe%2C%20J.%2C%20Doherty%2C%20D.%20G.%2C%20%26amp%3B%20Molloy%2C%20E.%20J.%20%282021%29.%20Melatonin%20as%20an%20immunomodulator%20in%20children%20with%20Down%20syndrome.%20%3Ci%3EPediatric%20Research%3C%5C%2Fi%3E%2C%201%26%23x2013%3B9.%20%3Ca%20class%3D%27zp-DOIURL%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41390-021-01611-6%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41390-021-01611-6%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D6445218%26amp%3Bitem_key%3DTZQ3WXU5%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Melatonin%20as%20an%20immunomodulator%20in%20children%20with%20Down%20syndrome%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dean%22%2C%22lastName%22%3A%22Huggard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lynne%22%2C%22lastName%22%3A%22Kelly%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amy%22%2C%22lastName%22%3A%22Worrall%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eleanor%22%2C%22lastName%22%3A%22Gallagher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lida%22%2C%22lastName%22%3A%22Fallah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lucas%20Lu%22%2C%22lastName%22%3A%22Yoo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fiona%22%2C%22lastName%22%3A%22McGrane%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Niamh%22%2C%22lastName%22%3A%22Lagan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edna%22%2C%22lastName%22%3A%22Roche%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joanne%22%2C%22lastName%22%3A%22Balfe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Derek%20G.%22%2C%22lastName%22%3A%22Doherty%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eleanor%20J.%22%2C%22lastName%22%3A%22Molloy%22%7D%5D%2C%22abstractNote%22%3A%22Down%20syndrome%20%28DS%29%20is%20a%20disorder%20characterised%20by%20marked%20immune%20dysfunction%2C%20increased%20mortality%20from%20sepsis%2C%20chronic%20inflammation%2C%20increased%20oxidative%20stress%2C%20sleep%20disturbance%20and%20possibly%20abnormal%20endogenous%20melatonin%20levels.%20Melatonin%20has%20a%20myriad%20of%20immune%20functions%2C%20and%20we%20hypothesised%20that%20this%20therapeutic%20agent%20could%20modulate%20the%20innate%20immune%20system%20in%20this%20cohort.%22%2C%22date%22%3A%222021-08-16%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41390-021-01611-6%22%2C%22ISSN%22%3A%221530-0447%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.nature.com%5C%2Farticles%5C%2Fs41390-021-01611-6%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222021-08-17T00%3A13%3A34Z%22%7D%7D%5D%7D
Huggard, D., Kelly, L., Worrall, A., Gallagher, E., Fallah, L., Yoo, L. L., McGrane, F., Lagan, N., Roche, E., Balfe, J., Doherty, D. G., & Molloy, E. J. (2021). Melatonin as an immunomodulator in children with Down syndrome. Pediatric Research, 1–9. https://doi.org/10.1038/s41390-021-01611-6 Cite